Hugh McCloskey
Neuroinformatics Fellow
Hugh is completing a PhD at Cardiff University Engineering department and Cardiff University Brain Research Imaging Centre (CUBRIC), with a focus on the use of advanced Diffusion Imaging for the detection of sports-related white-matter microstructural injuries.
He is at SAHMRI as a Neuroinformatics Fellow to assist in deploying preprocessing pipelines for advanced diffusion data collected on the Siemens CIMAX scanner and to assist with neuroimaging data analytics.
Related News
First dementia treatment drug approved for Australia, supported by NIF capacity
Donanemab, developed by Lilly, is the first disease-modifying treatment for early-stage Alzheimer’s disease to be approved for use in Australia. The National Imaging Facility supported its developme
16 June 2025
New molecular-imaging network launched to benefit cancer, dementia imaging and new radiopharmaceuticals
A new national-scale molecular-imaging network that aims to improve cancer imaging, dementia diagnosis and treatment, and new radiopharmaceuticals was launched Saturday at the annual meeting for Austr
26 May 2025
SAHMRI’s cyclotron: a decade of quiet achievement
For 10 years, SAHMRI’s Cyclotron and Radiochemistry Facility has been a quiet powerhouse in Australian medical research—advancing precision imaging and improving patient outcomes.
12 March 2025
Amazon: Empowering epilepsy patients to live fully with AWS Cloud
AWS’s Artificial Intelligence is helping the Australian Epilepsy Project better understand epilepsy, and support doctors and patients in Australia make the diagnosis, treatment, and management of th
25 August 2024